Simple jQuery Dropdowns

Browsing by Author Khadeeja Mohamed

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Nov-2017A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M. Fukuda; Srivicha Krudsood; Khadeeja Mohamed; Justin A. Green; Sukhuma Warrasak; Harald Noedl; Ataya Euswas; Mali Ittiverakul; Nillawan Buathong; Sabaithip Sriwichai; R. Scott Miller; Colin Ohrt; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; GlaxoSmithKline plc.; Walter Reed Army Institute of Research; Medizinische Universitat Wien; Bangkok Hospital Medical Center; Bill and Melinda Gates Foundation; Consortium for Health Action
17-Jan-2019Single-dose tafenoquine to prevent relapse of plasmodium vivax malariaMarcus V.G. Lacerda; Alejandro Llanos-Cuentas; Srivicha Krudsood; Chanthap Lon; David L. Saunders; Rezika Mohammed; Daniel Yilma; Dhelio Batista Pereira; Fe E.J. Espino; Reginaldo Z. Mia; Raul Chuquiyauri; Fernando Val; Martín Casapía; Wuelton M. Monteiro; Marcelo A.M. Brito; Mônica R.F. Costa; Nillawan Buathong; Harald Noedl; Ermias Diro; Sisay Getie; Kalehiwot M. Wubie; Alemseged Abdissa; Ahmed Zeynudin; Cherinet Abebe; Mauro S. Tada; Françoise Brand; Hans Peter Beck; Brian Angus; Stephan Duparc; Jörg Peter Kleim; Lynda M. Kellam; Victoria M. Rousell; Siôn W. Jones; Elizabeth Hardaker; Khadeeja Mohamed; Donna D. Clover; Kim Fletcher; John J. Breton; Cletus O. Ugwuegbulam; Justin A. Green; Gavin C.K.W. Koh; GlaxoSmithKline, USA; University of Gondar; Gokila; Universidad Peruana Cayetano Heredia; Jimma University; University of Oxford; Fundacao Oswaldo Cruz; Universitat Basel; Mahidol University; Medizinische Universitat Wien; Medicines for Malaria Venture; Rio Tuba Nickel Foundation Hospital; Centro de Pesquisas em Medicina Tropical
17-Jan-2019Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malariaAlejandro Llanos-Cuentas; Marcus V.G. Lacerda; Tran T. Hien; Iván D. Vélez; Chayadol Namaik-Larp; Cindy S. Chu; Maria F. Villegas; Fernando Val; Wuelton M. Monteiro; Marcelo A.M. Brito; Mônica R.F. Costa; Raul Chuquiyauri; Martín Casapía; Chau H. Nguyen; Sandra Aruachan; Ratchadaporn Papwijitsil; François H. Nosten; Germana Bancone; Brian Angus; Stephan Duparc; Graham Craig; Victoria M. Rousell; Siôn W. Jones; Elizabeth Hardaker; Donna D. Clover; Lindsay Kendall; Khadeeja Mohamed; Gavin C.K.W. Koh; Viviana M. Wilches; John J. Breton; Justin A. Green; GlaxoSmithKline, USA; Universidad Peruana Cayetano Heredia; Universidad de Antioquia; University of Oxford; Fundacao Oswaldo Cruz; GlaxoSmithKline plc.; Mahidol University; Medicines for Malaria Venture; IMAT Onco-medica; Centro de Investigaciones Clínicas; Oxford University Clinical Research Unit